Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma

Completed · Phase 1

Conditions studied: Lung Cancer, Malignant Mesothelioma

In brief

RATIONALE: Vaccines made from a person's tumor may help the body build an immune response to kill tumor cells. PURPOSE: Phase I trial to study the effectiveness of vaccine therapy in treating patients who have undergone surgery to remove stage I, stage II, or stage IIIA non-small cell lung cancer or stage I or stage II mesothelioma.

Key facts

Study ID
NCT00003974
Run by
Roswell Park Cancer Institute
People needed
20
Starts
1997-08-01
Expected to finish
2000-11-01
Last updated by the study team
2011-03-07

Who can join

Age: 20 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.